High-Throughput IVD Design and Development Pipeline
Our R&D headquarters based in the heart of Provence, France provide the ideal playground for our research team to innovate and develop robust IVD designs.
From molecular chemistry to enzymology to bioinformatics to clinical testing to quality management systems, we have developed a strong know-how throughout the lifecycle of an IVD medical device.
Our Technology Platforms
Real-Time Loop Mediated Isothermal
Amplification 'RT-LAMP'
Cutting-Edge molecular chemistry that delivers highly sensitive and specific results in under 30 minutes. It holds the potential to replace real-time PCR for qualitative detection of DNA/RNA across a wide variety of applications.
Real-Time Polymerase
Chain Reaction
'RT-PCR'
Gold-Standard molecular chemistry that is used for the detection and quantification of DNA/RNA nucleic acids across a wide variety of applications.
Real-Time Loop Mediated Isothermal Amplification
'RT-LAMP'
We specialise in this cutting-edge molecular diagnostic technology platform that
reduces processing time by a factor of 3x compared to conventional RT-PCR testing.
Design & Development
Pipeline
Design
Development
Design
Verification
Clinical
Validation
Regulatory
Review
Post Market
Surveillance
Black fungus
Bocavirus
Bordetella parapertussis
Bordetella pertussis
Candida Albicans
Chikungunya
Chlamydia pneumoniae
Chlamydia trachomatis
Clostridium difficile
Clostridium perfringens
Cryptococcus neoformans/gattii
Cytomegalovirus
Dengue
Enterovirus
Epstein-Barr virus
Group A Streptococcus
Haemophilus influenzae
Helicobacter pylori
Hepatitis A Virus
Hepatitis B Virus
Hepatitis C Virus
Hepatitis D Virus
Hepatitis E Virus
Hepatitis G Virus
Herpes simplex virus 1 and 2
HIV-1 and 2
HPV-16/HPV-18
Human adenovirus
Human Herpes Virus 6/7/8
Human Metapneumo virus A/B
Influenza A
Influenza A (H1N1) 2009
Influenza A (H3N2)
Influenza A (H5N1)
Influenza B
Influenza C
Japanese Encephalitis
John Cunningham Virus
Klebsiella pneumoniae
Legionella
Leishmania parasites (Kala azar)
Leptospira
Listeria spp.
Monkeypox virus
Moraxella catarrhalis
Mycobacterium avium complex
Mycobacterium leprae
Mycobacterium tuberculosis complex
Mycoplasma genitalium
Mycoplasma pneumoniae
Neisseria gonorrhoeae
Norovirus1&II
Parainfluenza virus 1/2/3/4
Parvovirus B19 (B19V)
Plasmodium falciparum (Malaria)
Pneumocystis jiroveci
Polyomavirus hominis 1 (BK Virus)
Respiratory Syncytial Virus
Rhino Virus
Rotavirus
Salmonella Spp.
SARS-CoV-2
Shigella Spp.
Staphylococcus aureus (SA)
Streptococcus pneumoniae
Treponema pallidum
Trichomonas vaginalis
Varicella-zoster virus (VZV)
West Nile virus
Yellow Fever Virus
Yersinia enterocolitica
Zika virus
* Note: The list provides an overview of the stage of development of an infectious pathogen on the basis of the status of the IVD design (RT-LAMP or RT-PCR) at the most advanced stage of development.
IVD Medical Devices
Nearing Marketing Authorisation
Mycobacterium Tuberculosis
Nature of IVD: Qualitative
Technology Principle: RT-LAMP
Internal Control: Endogenous
Assay Time: <20 Minutes
Development Stage: Clinical Evaluation
Hepatitis B Virus
Nature of IVD: Quantitative
Technology Principle: RT-PCR
Development Stage: Regulatory Review